Delivery Order SPE2DB20D1100-SPE2DB24FB1F3
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,664.24 firm fixed-price delivery order is for the supply of 4559656211 GLATIRAMER 40 MG/ML syringes, with a completion date of January 20, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,088.20 firm fixed-price delivery order contract is for the supply of GLATIRAMER 40 MG/ML SYRINGE medication, with a period of performance through July 11, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award is for the delivery of GLATIRAMER 40 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $10,837.26 and a period of performance through February 6, 2024. This award does not have a set-aside designation, indicating it was competed...
- This is a $15,934.50 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4563282445 GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product. No set-aside was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a $6,973.17 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Glatiramer 40 mg/ml syringes, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The award, valued at $5,650.68, is a firm fixed price delivery order for the supply of GLATOPA 40 mg/ml syringes. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, that serves as the primary vehicle for the company to provide pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,377.68 Firm Fixed Price delivery order is for the supply of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a period of performance through May 10, 2022 and does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- The Defense Logistics Agency awarded a $3,666.66 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4562084498, Glatiramer 40 mg/ml syringes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 8, 2023 under a firm fixed price arrangement. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to support military readiness by...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, involves the supply of GLATOPA 20 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $29,828.32, was issued as a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA that has a ceiling value of up to $999,999,999 through December 2025. This contract does not have a set-aside designation. Amerisourcebergen, a major...
- The Defense Logistics Agency awarded a delivery order valued at $34,084.53 to AmerisourceBergen Drug Corp for Glatopa 40 mg/ml syringes, with an ultimate completion date of September 29, 2025. This is a firm fixed price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 prime vendor agreement running through December 2026. The product will be performed and delivered from...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB1F3Delivery Order
This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $18,030.03 firm fixed price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product, to support the requirements of the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The current award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 4/4/24 |